Pharmacist-led smoking cessation programs: A comprehensive review of effectiveness, implementation models, and future directions
1 Novartis Nigeria Limited, Nigeria.
2 Alltymz Pharmacy Ltd, Port-Harcourt, Nigeria.
Review
International Journal of Science and Technology Research Archive, 2022, 03(02), 297-304.
Article DOI: 10.53771/ijstra.2022.3.2.0129
Publication history:
Received on 02 October 2022; revised on 19 November 2022; accepted on 22 November 2022
Abstract:
Pharmacist-led smoking cessation programs have emerged as effective interventions in addressing the global tobacco epidemic, leveraging the accessibility and expertise of pharmacists to provide tailored behavioral counseling, pharmacological support, and follow-up care. This review examines the effectiveness of these programs, highlighting their ability to achieve higher quit rates, improved patient satisfaction, and cost-effectiveness compared to traditional methods. Various implementation models, including those in community pharmacies, hospital settings, and telehealth platforms, are explored, along with the challenges of scaling these interventions, such as limited awareness, training gaps, and inadequate reimbursement. Future directions emphasize innovations in digital tools, personalized medicine, artificial intelligence, and policy and funding support to enhance program reach and sustainability. Recommendations are provided for pharmacists, healthcare systems, and policymakers to address barriers, expand access, and foster collaboration, ultimately integrating pharmacist-led smoking cessation into mainstream healthcare as a critical strategy for tobacco control.
Keywords:
Pharmacist-led programs; Smoking cessation; Behavioral counseling; Public health; Telehealth interventions; Personalized medicine
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0